Generate a tailored SOP for Dr. Brandon Bordeau. Improve your application with a focused, well-structured draft.
Brandon Bordeau is an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Michigan. He earned his Ph.D. in Pharmaceutical Sciences from the University at Buffalo in 2020 and his B.S. in Biochemistry from Binghamton University in 2015. His research focuses on developing innovative antibody-based therapies, capitalizing on the significant advantages of antibodies due to their remarkable adaptability and engineering versatility. Bordeau employs pharmacokinetic modeling and simulation to identify key antibody attributes, including target binding affinity, clearance rates, valency, and molecular size. The findings from these simulations inform his antibody engineering campaigns to develop lead antibody therapies for experimental testing. His laboratory investigates Antibody Drug Complexes (ADCx), Antibody PROTAC conjugates, and antibody-targeted cytokine therapies. With previous roles including Research Assistant Professor at the University at Buffalo and co-founder of Abceutics Inc., he is actively engaged in advancing the field of pharmaceutical sciences through innovative research and collaboration.
University of Michigan • Ann Arbor, MI
Teaching and conducting research in the Department of Pharmaceutical Sciences.
Abceutics Inc. •
Leading a biotech company focused on antibody drug development.
University Buffalo •
Conducting research and teaching in the Department of Pharmaceutical Sciences.
Department of Electrical Engineering and Computer Science